C4 Therapeutics, Inc. (CCCC) — SC 13G Filings
All SC 13G filings from C4 Therapeutics, Inc.. Browse 7 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (7)
- SC 13G Filing — Nov 14, 2024
- SC 13G Filing — Nov 8, 2024
- SC 13G Filing — Oct 22, 2024
- SC 13G Filing — Apr 10, 2024
-
Soleus Capital Discloses Significant Stake in C4 Therapeutics
— Feb 5, 2024
Soleus Capital Master Fund, L.P., a Cayman Islands-based investment fund, reported beneficial ownership of C4 Therapeutics, Inc. common stock as of January 26, -
Betta Investment Takes 9.9% Stake in C4 Therapeutics
— Jan 12, 2024
Betta Investment (Hong Kong) Ltd. has reported a significant stake in C4 Therapeutics, Inc., acquiring sole voting and dispositive power over 5,567,928 shares o -
Point72 Takes 5.1% Stake in C4 Therapeutics
— Jan 4, 2024
Point72 Asset Management, L.P. has disclosed a significant stake in C4 Therapeutics, Inc., beneficially owning 2,312,059 shares of common stock as of January 3,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX